RA
CMRX

Rosalind Advisors’s Chimerix, Inc. CMRX Stock Holding History

Rosalind Advisors’s Portfolio CMRX Stock Details CMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-3,050,000
Closed -$10.6M – 47
2024
Q4 		$10.6M Buy
+3,050,000
New +$4.3M 5.43% 4

Other funds holding CMRX

BCM
Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KC
Kryger Capital London, United Kingdom $1.41B AUM 86.31% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
FTCM
First Trust Capital Management Chicago, Illinois $1.9B AUM 58.39% 1-Year Est. Return

Rosalind Advisors's CMRX Position: Q1 2025 in Review

Rosalind Advisors sold out of Chimerix, Inc. (CMRX) in Q1 2025, closing a stake of 3,050,000 shares — an estimated $10.6M sold.

Rosalind Advisors first reported a position in CMRX in Q4 2024 and held it in 1 quarter. The position peaked at $10.6M in Q4 2024. 119 funds tracked by Wall St. Rank hold CMRX as of Q1 2025.

  • Rosalind Advisors reported no remaining Chimerix, Inc. position as of Q1 2025 after selling out during the quarter.
  • Rosalind Advisors sold 3,050,000 Chimerix, Inc. shares in Q1 2025, an estimated $10.6M.
  • Rosalind Advisors first reported a position in Chimerix, Inc. in Q4 2024 and held it in 1 quarter.
  • Rosalind Advisors's Chimerix, Inc. position peaked at $10.6M in Q4 2024.
  • 119 funds tracked by Wall St. Rank held Chimerix, Inc. as of Q1 2025.

Based on Rosalind Advisors's 13F filing for Q1 2025, filed 14 May 2025.